Functionalised carbon nanotubes: high biocompatibility with lack of toxicity
by M. Antonia Herrero; Lara Lacerda; Alberto Bianco; Kostas Kostarelos; Maurizio Prato
International Journal of Nanotechnology (IJNT), Vol. 8, No. 10/11/12, 2011

Abstract: Recent studies from our laboratories have clearly shown the utility of the carbon nanotubes (CNTs) in biomedical applications. Therefore, the behaviour of CNTs following in vivo administration is of high interest. In this paper, we summarise some of our previously published results towards the assessment of the health impact of CNTs. We will initially describe the in vivo distribution of radiolabelled multi-walled CNTs (MWNTs) once they reach systemic circulation using micro Single Photon Emission Tomography (microSPECT) imaging and scintillation counting. Our conclusions on the effect of CNT degree of functionalisation on the tissue accumulation will also be described. Finally, our proposed mechanism of CNT elimination from the body through the kidney glomerular filtration barrier will be shown. Overall, through this overview of our recent studies we offer a summary of why we believe the development of functionalised carbon nanotubes can be further explored since it increasingly offers biocompatible material with lack of toxic responses.

Online publication date: Fri, 23-Dec-2011

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email